EMQN CIC

EMQN is the leading global provider of quality assurance tools and knowledge to the human molecular pathology and genetic testing community in the form of External Quality Assessment (EQA) schemes, also referred to as proficiency testing (PT). This assures the best possible clinical diagnostics test execution, accuracy, performance, interpretation, and reporting. Furthermore, EMQNs highly qualified peer group of assessors take pride in their thought leadership position by their commitment to regularly publishing best practice guidelines. We believe that every patient should have the most accurate diagnostic test result possible. After all, many lives may depend on a correct diagnosis and...

Quality assurance,external quality assessment (eqa),proficiency testing (pt),genetics,pathology,oncology,pharmaceuticals,clinical diagnostics,best practice,guidelines,harmonisation,and laboratory

Emqn cic operates in the Hospitals and health care industry.

Emqn cic's revenue is 11m - 100m

Emqn cic has 11 - 50 employees.